GT Biopharma (GTBP) Inventory (2011 - 2014)
GT Biopharma's (GTBP) quarterly Inventory came in at $42000.0 in Q1 2014, down 55.32% year-over-year from $94000.0 in Q1 2013, and little changed quarter-over-quarter from $42000.0 in Q4 2013.
Analysis
GT Biopharma (GTBP) Inventory (2011 - 2014) Analysis & Trends
GT Biopharma (GTBP) has reported Inventory for 4 consecutive years, with $42000.0 the latest figure, recorded in Q1 2014.
- On a quarterly basis, Inventory fell 55.32% year-over-year to $42000.0 in Q1 2014; TTM through Mar 2014 was $42000.0, a 55.32% decrease from a year earlier, with the FY2013 full-year figure at $42000.0, down 28.81% from the prior year.
- Inventory was $42000.0 for Q1 2014 at GT Biopharma, roughly flat from $42000.0 in the prior quarter.
- Over five years, Inventory peaked at $94000.0 in Q1 2013 and troughed at $12000.0 in Q4 2011.
- A 4-year average of $50428.6 and a median of $42000.0 in 2013 frame the typical range for Inventory.
- Across the five-year window, Inventory jumped 683.33% in 2013 and slumped 55.32% in 2014, its largest moves.
- Over 4 years, Inventory stood at $12000.0 in 2011, then jumped by 391.67% to $59000.0 in 2012, then dropped by 28.81% to $42000.0 in 2013, then changed by 0.0% to $42000.0 in 2014.
- The last three Inventory figures came in at $42000.0 (Q1 2014), $42000.0 (Q4 2013), and $94000.0 (Q1 2013), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 6.22 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 1.95 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 3.08 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 371.00 Mn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 280.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 2.38 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 142.38 Mn |
| 10 | GT Biopharma | 337,746.23 | 337,746.23 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2014 | 42,000.00 |
| Dec 31, 2013 | 42,000.00 |
| Mar 31, 2013 | 94,000.00 |
| Dec 31, 2012 | 59,000.00 |
| Jun 30, 2012 | 92,000.00 |
| Mar 31, 2012 | 12,000.00 |
| Dec 31, 2011 | 12,000.00 |